• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Adaptive Biotechnologies Corporation - Common Stock (NQ:ADPT)

10.87 +0.34 (+3.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Adaptive Biotechnologies Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought
June 02, 2023
There are always stocks to buy if you're Ark Invest's ace stock picker. 
Via The Motley Fool
Adaptive Biotechnologies Highlights New Data at ASCO 2023 and EHA 2023 Underscoring the clonoSEQ® Assay’s Impact as a Standard for Minimal Residual Disease Assessment in Patients with Hematologic Cancer
June 02, 2023
From Adaptive Biotechnologies
Via GlobeNewswire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
May 26, 2023
There are always stocks to buy if you're Ark Invest's ace stock picker. 
Via The Motley Fool
Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences
May 24, 2023
From Adaptive Biotechnologies
Via GlobeNewswire
3 Personalized Medicine Stocks to Buy for Long-Time Returns
May 15, 2023
Personalized medicine is the future of medicine. Here are three personalized medicine stocks to invest in so you don't miss out. 
Via InvestorPlace
Adaptive Biotechnologies's Return On Capital Employed Insights
May 11, 2023
Via Benzinga
Adaptive Biotechnologies: Q1 Earnings Insights
May 03, 2023
Via Benzinga
What To Know About Piper Sandler's Upgrade of Adaptive Biotechnologies
December 21, 2022
Via Benzinga
Adaptive Biotechnologies to Participate in the 2023 RBC Capital Markets Global Healthcare Conference
May 12, 2023
From Adaptive Biotechnologies
Via GlobeNewswire
Adaptive Biotechnologies Announces FDA Acceptance of Genentech’s Investigational New Drug Application for the First Neoantigen-Directed T-Cell Therapy Product in Oncology
May 09, 2023
The T-Cell Therapy product candidate contains a neoantigen-specific T-cell receptor (TCR) identified and characterized through Adaptive’s TCR discovery platform 
From Adaptive Biotechnologies
Via GlobeNewswire
Adaptive Biotechnologies Reports First Quarter 2023 Financial Results
May 03, 2023
From Adaptive Biotechnologies
Via GlobeNewswire
Looking Into Adaptive Biotechnologies's Return On Capital Employed
November 25, 2022
Via Benzinga
Adaptive Biotechnologies to Participate in the BofA Securities 2023 Healthcare Conference
April 25, 2023
From Adaptive Biotechnologies
Via GlobeNewswire
Adaptive Biotechnologies Announces Translational Collaboration with Takeda to Measure Minimal Residual Disease with Its clonoSEQ® Assay Across Its Hematologic Malignancy Pipeline
April 12, 2023
Collaboration will cover existing and future programs to aid in the development and commercialization of investigational medicines for hematologic malignancies 
From Adaptive Biotechnologies
Via GlobeNewswire
Adaptive Biotechnologies to Report First Quarter Financial Results on May 3, 2023
April 06, 2023
From Adaptive Biotechnologies
Via GlobeNewswire
Luminar Technologies, EHang Holdings And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
March 22, 2023
U.S. stock futures traded slightly lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Adaptive Biotechnologies to Participate in the 43rd Annual Cowen Healthcare Conference
February 27, 2023
From Adaptive Biotechnologies
Via GlobeNewswire
Trade Desk, Roblox, Herbalife And Other Big Stocks Moving Higher On Wednesday
February 15, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results
February 14, 2023
From Adaptive Biotechnologies
Via GlobeNewswire
Earnings Scheduled For February 14, 2023
February 14, 2023
Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion. 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 13, 2023
Via Benzinga
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 14, 2023
January 23, 2023
From Adaptive Biotechnologies
Via GlobeNewswire
Adaptive Biotechnologies to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 27, 2022
From Adaptive Biotechnologies
Via GlobeNewswire
Nike, FedEx And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
December 21, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga
Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session
December 21, 2022
Gainers Sintx Technologies, Inc. (NASDAQ: SINT) shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical... 
Via Benzinga
Adaptive Biotechnologies Highlights New Data Showcasing the Clinical Utility of clonoSEQ® MRD Testing in Patients with Blood Cancers at the 64th ASH Annual Meeting
December 10, 2022
From Adaptive Biotechnologies
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
December 21, 2022
Via Benzinga
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Clinical Utility and Benefit of clonoSEQ® MRD Testing in Blood Cancer Patients at 2022 ASH Annual Meeting
December 05, 2022
From Adaptive Biotechnologies
Via GlobeNewswire
Adaptive Biotechnologies Announces Launch of clonoSEQ® to Assess Minimal Residual Disease (MRD) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Using Circulating Tumor DNA (ctDNA)
December 01, 2022
From Adaptive Biotechnologies
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap